nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—hypertension—metabolic syndrome X	0.952	1	CtDrD
Guanabenz—Appetite absent—Metformin—metabolic syndrome X	0.00269	0.0693	CcSEcCtD
Guanabenz—Nail disorder—Metformin—metabolic syndrome X	0.00206	0.0532	CcSEcCtD
Guanabenz—Accidental injury—Metformin—metabolic syndrome X	0.00151	0.039	CcSEcCtD
Guanabenz—Injury—Metformin—metabolic syndrome X	0.00106	0.0272	CcSEcCtD
Guanabenz—Hypoglycaemia—Metformin—metabolic syndrome X	0.000995	0.0257	CcSEcCtD
Guanabenz—Dehydration—Metformin—metabolic syndrome X	0.000903	0.0233	CcSEcCtD
Guanabenz—Liver function test abnormal—Metformin—metabolic syndrome X	0.000896	0.0231	CcSEcCtD
Guanabenz—Breast disorder—Metformin—metabolic syndrome X	0.000877	0.0226	CcSEcCtD
Guanabenz—Cramp muscle—Metformin—metabolic syndrome X	0.000874	0.0225	CcSEcCtD
Guanabenz—Abdominal distension—Metformin—metabolic syndrome X	0.000845	0.0218	CcSEcCtD
Guanabenz—Influenza—Metformin—metabolic syndrome X	0.000839	0.0216	CcSEcCtD
Guanabenz—Abdominal discomfort—Metformin—metabolic syndrome X	0.000804	0.0207	CcSEcCtD
Guanabenz—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00078	0.0201	CcSEcCtD
Guanabenz—Infestation NOS—Metformin—metabolic syndrome X	0.000748	0.0193	CcSEcCtD
Guanabenz—Infestation—Metformin—metabolic syndrome X	0.000748	0.0193	CcSEcCtD
Guanabenz—Oedema peripheral—Metformin—metabolic syndrome X	0.000662	0.0171	CcSEcCtD
Guanabenz—Connective tissue disorder—Metformin—metabolic syndrome X	0.00066	0.017	CcSEcCtD
Guanabenz—Eye disorder—Metformin—metabolic syndrome X	0.000628	0.0162	CcSEcCtD
Guanabenz—Immune system disorder—Metformin—metabolic syndrome X	0.000607	0.0156	CcSEcCtD
Guanabenz—Mediastinal disorder—Metformin—metabolic syndrome X	0.000605	0.0156	CcSEcCtD
Guanabenz—Chills—Metformin—metabolic syndrome X	0.000603	0.0155	CcSEcCtD
Guanabenz—Malnutrition—Metformin—metabolic syndrome X	0.000585	0.0151	CcSEcCtD
Guanabenz—Erythema—Metformin—metabolic syndrome X	0.000585	0.0151	CcSEcCtD
Guanabenz—Flatulence—Metformin—metabolic syndrome X	0.000576	0.0149	CcSEcCtD
Guanabenz—Muscle spasms—Metformin—metabolic syndrome X	0.000562	0.0145	CcSEcCtD
Guanabenz—Vision blurred—Metformin—metabolic syndrome X	0.000551	0.0142	CcSEcCtD
Guanabenz—Ill-defined disorder—Metformin—metabolic syndrome X	0.000543	0.014	CcSEcCtD
Guanabenz—Malaise—Metformin—metabolic syndrome X	0.000527	0.0136	CcSEcCtD
Guanabenz—Syncope—Metformin—metabolic syndrome X	0.000524	0.0135	CcSEcCtD
Guanabenz—Loss of consciousness—Metformin—metabolic syndrome X	0.000514	0.0133	CcSEcCtD
Guanabenz—Hypertension—Metformin—metabolic syndrome X	0.000505	0.013	CcSEcCtD
Guanabenz—Myalgia—Metformin—metabolic syndrome X	0.000498	0.0128	CcSEcCtD
Guanabenz—Chest pain—Metformin—metabolic syndrome X	0.000498	0.0128	CcSEcCtD
Guanabenz—Discomfort—Metformin—metabolic syndrome X	0.000492	0.0127	CcSEcCtD
Guanabenz—Oedema—Metformin—metabolic syndrome X	0.000477	0.0123	CcSEcCtD
Guanabenz—Infection—Metformin—metabolic syndrome X	0.000474	0.0122	CcSEcCtD
Guanabenz—Shock—Metformin—metabolic syndrome X	0.000469	0.0121	CcSEcCtD
Guanabenz—Nervous system disorder—Metformin—metabolic syndrome X	0.000468	0.0121	CcSEcCtD
Guanabenz—Thrombocytopenia—Metformin—metabolic syndrome X	0.000467	0.012	CcSEcCtD
Guanabenz—Skin disorder—Metformin—metabolic syndrome X	0.000464	0.012	CcSEcCtD
Guanabenz—Anorexia—Metformin—metabolic syndrome X	0.000455	0.0117	CcSEcCtD
Guanabenz—Hypotension—Metformin—metabolic syndrome X	0.000446	0.0115	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000435	0.0112	CcSEcCtD
Guanabenz—Paraesthesia—Metformin—metabolic syndrome X	0.000429	0.0111	CcSEcCtD
Guanabenz—Dyspnoea—Metformin—metabolic syndrome X	0.000425	0.011	CcSEcCtD
Guanabenz—Dyspepsia—Metformin—metabolic syndrome X	0.00042	0.0108	CcSEcCtD
Guanabenz—Decreased appetite—Metformin—metabolic syndrome X	0.000415	0.0107	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000412	0.0106	CcSEcCtD
Guanabenz—Fatigue—Metformin—metabolic syndrome X	0.000411	0.0106	CcSEcCtD
Guanabenz—Constipation—Metformin—metabolic syndrome X	0.000408	0.0105	CcSEcCtD
Guanabenz—Feeling abnormal—Metformin—metabolic syndrome X	0.000393	0.0101	CcSEcCtD
Guanabenz—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00039	0.0101	CcSEcCtD
Guanabenz—Urticaria—Metformin—metabolic syndrome X	0.000379	0.00978	CcSEcCtD
Guanabenz—Abdominal pain—Metformin—metabolic syndrome X	0.000377	0.00973	CcSEcCtD
Guanabenz—Asthenia—Metformin—metabolic syndrome X	0.000342	0.00883	CcSEcCtD
Guanabenz—Pruritus—Metformin—metabolic syndrome X	0.000338	0.00871	CcSEcCtD
Guanabenz—Diarrhoea—Metformin—metabolic syndrome X	0.000327	0.00842	CcSEcCtD
Guanabenz—Dizziness—Metformin—metabolic syndrome X	0.000316	0.00814	CcSEcCtD
Guanabenz—Vomiting—Metformin—metabolic syndrome X	0.000303	0.00782	CcSEcCtD
Guanabenz—Rash—Metformin—metabolic syndrome X	0.000301	0.00776	CcSEcCtD
Guanabenz—Dermatitis—Metformin—metabolic syndrome X	0.000301	0.00775	CcSEcCtD
Guanabenz—Headache—Metformin—metabolic syndrome X	0.000299	0.00771	CcSEcCtD
Guanabenz—Nausea—Metformin—metabolic syndrome X	0.000283	0.00731	CcSEcCtD
Guanabenz—ADRA2A—Metabolism—HDAC3—metabolic syndrome X	1.09e-05	0.00116	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—IGF1—metabolic syndrome X	1.08e-05	0.00116	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—CCL5—metabolic syndrome X	1.08e-05	0.00116	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—HTR2C—metabolic syndrome X	1.07e-05	0.00115	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MTNR1B—metabolic syndrome X	1.07e-05	0.00115	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GCKR—metabolic syndrome X	1.06e-05	0.00114	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—LPA—metabolic syndrome X	1.06e-05	0.00114	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CNR1—metabolic syndrome X	1.06e-05	0.00113	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—APOA1—metabolic syndrome X	1.05e-05	0.00113	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—NOS3—metabolic syndrome X	1.05e-05	0.00112	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	1.04e-05	0.00112	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—NAMPT—metabolic syndrome X	1.04e-05	0.00112	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TRIB3—metabolic syndrome X	1.04e-05	0.00112	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—RBP4—metabolic syndrome X	1.04e-05	0.00112	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	1.04e-05	0.00111	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—LIPC—metabolic syndrome X	1.04e-05	0.00111	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—GCK—metabolic syndrome X	1.04e-05	0.00111	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—APOC3—metabolic syndrome X	1.03e-05	0.0011	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PLA2G6—metabolic syndrome X	1.03e-05	0.0011	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—SERPINE1—metabolic syndrome X	1.03e-05	0.0011	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—ALB—metabolic syndrome X	1.03e-05	0.0011	CbGpPWpGaD
Guanabenz—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—metabolic syndrome X	1.02e-05	0.00109	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—FMO3—metabolic syndrome X	1.02e-05	0.00109	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOA5—metabolic syndrome X	1.02e-05	0.00109	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—GHRL—metabolic syndrome X	1.01e-05	0.00109	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—CCL5—metabolic syndrome X	1.01e-05	0.00108	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	1.01e-05	0.00108	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CETP—metabolic syndrome X	1e-05	0.00107	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—CCL2—metabolic syndrome X	1e-05	0.00107	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MTNR1B—metabolic syndrome X	9.99e-06	0.00107	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CCL5—metabolic syndrome X	9.82e-06	0.00105	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—NOS3—metabolic syndrome X	9.81e-06	0.00105	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—PLA2G4A—metabolic syndrome X	9.78e-06	0.00105	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TRIB3—metabolic syndrome X	9.74e-06	0.00104	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—RBP4—metabolic syndrome X	9.74e-06	0.00104	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	9.65e-06	0.00103	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CNR1—metabolic syndrome X	9.61e-06	0.00103	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—SCARB1—metabolic syndrome X	9.59e-06	0.00103	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—TRIB3—metabolic syndrome X	9.46e-06	0.00101	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	9.37e-06	0.001	CbGpPWpGaD
Guanabenz—ADRA2B—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	9.37e-06	0.001	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—SREBF1—metabolic syndrome X	9.31e-06	0.000997	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOC3—metabolic syndrome X	9.23e-06	0.000989	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CCL5—metabolic syndrome X	9.17e-06	0.000982	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PLA2G4A—metabolic syndrome X	9.13e-06	0.000978	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	9.12e-06	0.000976	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—MLXIPL—metabolic syndrome X	9.09e-06	0.000974	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—EPHX2—metabolic syndrome X	9.09e-06	0.000974	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HDAC3—metabolic syndrome X	9.08e-06	0.000972	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—HMGCR—metabolic syndrome X	9.06e-06	0.00097	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—GOT2—metabolic syndrome X	9.06e-06	0.00097	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—AGT—metabolic syndrome X	9.04e-06	0.000968	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—IGF1—metabolic syndrome X	8.79e-06	0.000941	CbGpPWpGaD
Guanabenz—ADRA2C—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	8.75e-06	0.000937	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOC3—metabolic syndrome X	8.62e-06	0.000924	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—G6PC2—metabolic syndrome X	8.55e-06	0.000915	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—NAMPT—metabolic syndrome X	8.48e-06	0.000908	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—AGT—metabolic syndrome X	8.45e-06	0.000904	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GCK—metabolic syndrome X	8.43e-06	0.000903	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—LIPC—metabolic syndrome X	8.43e-06	0.000903	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOC3—metabolic syndrome X	8.38e-06	0.000897	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—SERPINE1—metabolic syndrome X	8.35e-06	0.000894	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HTR2C—metabolic syndrome X	8.33e-06	0.000892	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—ALB—metabolic syndrome X	8.33e-06	0.000892	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—AGT—metabolic syndrome X	8.21e-06	0.000879	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—CCL5—metabolic syndrome X	8.2e-06	0.000878	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CETP—metabolic syndrome X	8.13e-06	0.000871	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	8.13e-06	0.00087	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MTNR1B—metabolic syndrome X	8.12e-06	0.000869	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—SLC2A4—metabolic syndrome X	8.07e-06	0.000864	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—ABCA1—metabolic syndrome X	8.07e-06	0.000864	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CYBA—metabolic syndrome X	8.07e-06	0.000864	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—NOS3—metabolic syndrome X	7.97e-06	0.000853	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TRIB3—metabolic syndrome X	7.91e-06	0.000847	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RBP4—metabolic syndrome X	7.91e-06	0.000847	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—GHRL—metabolic syndrome X	7.9e-06	0.000846	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	7.87e-06	0.000843	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—GOT1—metabolic syndrome X	7.82e-06	0.000837	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—GGT1—metabolic syndrome X	7.82e-06	0.000837	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—SCARB1—metabolic syndrome X	7.79e-06	0.000834	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HTR2C—metabolic syndrome X	7.78e-06	0.000834	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—AGT—metabolic syndrome X	7.67e-06	0.000821	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—SREBF1—metabolic syndrome X	7.56e-06	0.00081	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CYBA—metabolic syndrome X	7.54e-06	0.000807	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CNR1—metabolic syndrome X	7.48e-06	0.000801	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CCL5—metabolic syndrome X	7.45e-06	0.000798	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	7.42e-06	0.000794	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—GHRL—metabolic syndrome X	7.38e-06	0.00079	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—HMGCR—metabolic syndrome X	7.36e-06	0.000788	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GOT2—metabolic syndrome X	7.36e-06	0.000788	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—FABP4—metabolic syndrome X	7.27e-06	0.000778	CbGpPWpGaD
Guanabenz—ADRA2A—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	7.11e-06	0.000761	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOC3—metabolic syndrome X	7.01e-06	0.00075	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CNR1—metabolic syndrome X	6.99e-06	0.000748	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—TGFB1—metabolic syndrome X	6.94e-06	0.000744	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HSD11B1—metabolic syndrome X	6.89e-06	0.000738	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AGT—metabolic syndrome X	6.86e-06	0.000735	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—CCL2—metabolic syndrome X	6.76e-06	0.000724	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	6.68e-06	0.000715	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—APOB—metabolic syndrome X	6.63e-06	0.00071	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ABCA1—metabolic syndrome X	6.56e-06	0.000702	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—SLC2A4—metabolic syndrome X	6.56e-06	0.000702	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	6.5e-06	0.000696	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—TGFB1—metabolic syndrome X	6.49e-06	0.000695	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PLA2G4A—metabolic syndrome X	6.45e-06	0.000691	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	6.38e-06	0.000683	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GGT1—metabolic syndrome X	6.35e-06	0.00068	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GOT1—metabolic syndrome X	6.35e-06	0.00068	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—LPL—metabolic syndrome X	6.33e-06	0.000678	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HTR2C—metabolic syndrome X	6.32e-06	0.000677	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—CCL2—metabolic syndrome X	6.32e-06	0.000676	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AGT—metabolic syndrome X	6.23e-06	0.000667	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—G6PD—metabolic syndrome X	6.14e-06	0.000658	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CYBA—metabolic syndrome X	6.12e-06	0.000656	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IGF2—metabolic syndrome X	6.12e-06	0.000655	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	6.06e-06	0.000649	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CD36—metabolic syndrome X	6.02e-06	0.000644	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GHRL—metabolic syndrome X	5.99e-06	0.000642	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HDAC3—metabolic syndrome X	5.99e-06	0.000642	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOB—metabolic syndrome X	5.94e-06	0.000636	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GCKR—metabolic syndrome X	5.86e-06	0.000627	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LPA—metabolic syndrome X	5.86e-06	0.000627	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCL5—metabolic syndrome X	5.8e-06	0.000621	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PLA2G4A—metabolic syndrome X	5.78e-06	0.000619	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IGF2—metabolic syndrome X	5.71e-06	0.000612	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CNR1—metabolic syndrome X	5.68e-06	0.000608	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PLA2G6—metabolic syndrome X	5.67e-06	0.000608	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—LPL—metabolic syndrome X	5.67e-06	0.000607	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	5.63e-06	0.000603	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOA5—metabolic syndrome X	5.62e-06	0.000601	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PPARA—metabolic syndrome X	5.59e-06	0.000599	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOB—metabolic syndrome X	5.55e-06	0.000594	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	5.46e-06	0.000584	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—AGT—metabolic syndrome X	5.42e-06	0.00058	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCL5—metabolic syndrome X	5.42e-06	0.00058	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PLA2G4A—metabolic syndrome X	5.4e-06	0.000578	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOB—metabolic syndrome X	5.39e-06	0.000577	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	5.35e-06	0.000572	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—APOE—metabolic syndrome X	5.31e-06	0.000569	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—LPL—metabolic syndrome X	5.3e-06	0.000567	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	5.28e-06	0.000566	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—TGFB1—metabolic syndrome X	5.27e-06	0.000564	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—APOA1—metabolic syndrome X	5.25e-06	0.000562	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PLA2G4A—metabolic syndrome X	5.24e-06	0.000561	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—TRIB3—metabolic syndrome X	5.22e-06	0.000559	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—LPL—metabolic syndrome X	5.14e-06	0.000551	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CCL2—metabolic syndrome X	5.13e-06	0.000549	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CD36—metabolic syndrome X	4.89e-06	0.000523	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AGT—metabolic syndrome X	4.85e-06	0.000519	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—AKT1—metabolic syndrome X	4.83e-06	0.000517	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—LEP—metabolic syndrome X	4.75e-06	0.000509	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOE—metabolic syndrome X	4.75e-06	0.000509	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOA1—metabolic syndrome X	4.7e-06	0.000503	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	4.68e-06	0.000502	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	4.66e-06	0.000499	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LIPC—metabolic syndrome X	4.65e-06	0.000498	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GCK—metabolic syndrome X	4.65e-06	0.000498	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IGF2—metabolic syndrome X	4.64e-06	0.000497	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOC3—metabolic syndrome X	4.62e-06	0.000495	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PPARG—metabolic syndrome X	4.62e-06	0.000495	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPARA—metabolic syndrome X	4.54e-06	0.000487	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—INS—metabolic syndrome X	4.54e-06	0.000486	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AGT—metabolic syndrome X	4.53e-06	0.000485	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—AKT1—metabolic syndrome X	4.51e-06	0.000483	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOB—metabolic syndrome X	4.51e-06	0.000482	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CETP—metabolic syndrome X	4.49e-06	0.000481	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—LEP—metabolic syndrome X	4.44e-06	0.000475	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOE—metabolic syndrome X	4.44e-06	0.000475	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AGT—metabolic syndrome X	4.4e-06	0.000471	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCL5—metabolic syndrome X	4.4e-06	0.000471	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOA1—metabolic syndrome X	4.39e-06	0.00047	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	4.38e-06	0.000469	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOE—metabolic syndrome X	4.31e-06	0.000462	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LPL—metabolic syndrome X	4.3e-06	0.000461	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	4.3e-06	0.00046	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOA1—metabolic syndrome X	4.26e-06	0.000457	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IRS1—metabolic syndrome X	4.24e-06	0.000454	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	4.19e-06	0.000448	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	4.17e-06	0.000447	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—ALB—metabolic syndrome X	4.16e-06	0.000445	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	4.06e-06	0.000435	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GOT2—metabolic syndrome X	4.06e-06	0.000435	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—INS—metabolic syndrome X	4.06e-06	0.000435	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCL2—metabolic syndrome X	3.99e-06	0.000428	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—NOS3—metabolic syndrome X	3.98e-06	0.000426	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IRS1—metabolic syndrome X	3.96e-06	0.000424	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IGF1—metabolic syndrome X	3.93e-06	0.000421	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—INS—metabolic syndrome X	3.79e-06	0.000406	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPARG—metabolic syndrome X	3.76e-06	0.000402	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCL2—metabolic syndrome X	3.73e-06	0.0004	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SERPINE1—metabolic syndrome X	3.73e-06	0.000399	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—INS—metabolic syndrome X	3.68e-06	0.000395	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	3.68e-06	0.000394	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IGF1—metabolic syndrome X	3.67e-06	0.000393	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	3.66e-06	0.000392	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	3.66e-06	0.000392	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PTGS2—metabolic syndrome X	3.64e-06	0.00039	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	3.62e-06	0.000388	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	3.62e-06	0.000388	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	3.61e-06	0.000386	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	3.61e-06	0.000386	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	3.56e-06	0.000382	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NOS3—metabolic syndrome X	3.56e-06	0.000381	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GGT1—metabolic syndrome X	3.51e-06	0.000375	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GOT1—metabolic syndrome X	3.51e-06	0.000375	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SERPINE1—metabolic syndrome X	3.48e-06	0.000373	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ALB—metabolic syndrome X	3.38e-06	0.000362	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	3.33e-06	0.000356	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—NOS3—metabolic syndrome X	3.23e-06	0.000346	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	3.22e-06	0.000344	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	3.08e-06	0.00033	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	3.05e-06	0.000327	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	3.03e-06	0.000325	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—IL6—metabolic syndrome X	3e-06	0.000322	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	2.98e-06	0.000319	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOB—metabolic syndrome X	2.97e-06	0.000319	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	2.95e-06	0.000316	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	2.89e-06	0.00031	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	2.85e-06	0.000305	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LPL—metabolic syndrome X	2.84e-06	0.000304	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	2.83e-06	0.000303	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	2.81e-06	0.0003	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—AKT1—metabolic syndrome X	2.77e-06	0.000297	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	2.7e-06	0.000289	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CD36—metabolic syndrome X	2.7e-06	0.000289	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	2.59e-06	0.000277	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARA—metabolic syndrome X	2.51e-06	0.000269	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AGT—metabolic syndrome X	2.43e-06	0.00026	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOE—metabolic syndrome X	2.38e-06	0.000255	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TGFB1—metabolic syndrome X	2.35e-06	0.000252	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOA1—metabolic syndrome X	2.35e-06	0.000252	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	2.31e-06	0.000248	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	2.28e-06	0.000244	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	2.2e-06	0.000236	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	2.1e-06	0.000225	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARG—metabolic syndrome X	2.07e-06	0.000222	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—INS—metabolic syndrome X	2.03e-06	0.000218	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ALB—metabolic syndrome X	1.86e-06	0.0002	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—AKT1—metabolic syndrome X	1.83e-06	0.000196	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	1.79e-06	0.000191	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—NOS3—metabolic syndrome X	1.78e-06	0.000191	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL6—metabolic syndrome X	1.77e-06	0.00019	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	1.66e-06	0.000177	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AKT1—metabolic syndrome X	1.64e-06	0.000175	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	1.63e-06	0.000175	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	1.53e-06	0.000164	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AKT1—metabolic syndrome X	1.49e-06	0.000159	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	1.35e-06	0.000144	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	1.24e-06	0.000133	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AKT1—metabolic syndrome X	8.2e-07	8.78e-05	CbGpPWpGaD
